Illustrating How to Use the Validated Alsayed_v1 Tools to Improve Medical Care: A Particular Reference to the Global Initiative for Asthma 2022 Recommendations
暂无分享,去创建一个
[1] Bushra Alshammari,et al. Validation of an assessment, medical problem-oriented plan, and care plan tools for demonstrating the clinical pharmacist's activities , 2022, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.
[2] I. Basheti,et al. Evaluation of the effectiveness of educational medical informatics tutorial on improving pharmacy students’ knowledge and skills about the clinical problem-solving process , 2022, Pharmacy practice.
[3] Farhan F. Alshammari,et al. Perspectives of the community in the developing countries toward telemedicine and pharmaceutical care during the COVID-19 pandemic , 2022, Pharmacy practice.
[4] J. Drazen,et al. Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes. , 2021, The journal of allergy and clinical immunology. In practice.
[5] M. Bouvy,et al. Moral dilemmas of community pharmacists: a narrative study , 2017, International Journal of Clinical Pharmacy.
[6] G. Murtaza,et al. Randomized controlled trials covering pharmaceutical care and medicines management: A systematic review of literature , 2017, Research in social & administrative pharmacy : RSAP.
[7] Hua Shao,et al. Effect of pharmaceutical care on clinical outcomes of outpatients with type 2 diabetes mellitus , 2017, Patient preference and adherence.
[8] R. Clark,et al. Role of the Pharmacist for Improving Self-care and Outcomes in Heart Failure , 2017, Current Heart Failure Reports.
[9] S. Shrestha,et al. Benefit of hospital pharmacy intervention on the current status of dry powder inhaler technique in patients with asthma and COPD: a study from the Central Development Region, Nepal , 2016, Integrated pharmacy research & practice.
[10] I. Basheti,et al. Hospital pharmacy medication reconciliation practice in Jordan: perceptions and barriers. , 2016, Journal of evaluation in clinical practice.
[11] Maurílio de Souza Cazarim,et al. Impact Assessment of Pharmaceutical Care in the Management of Hypertension and Coronary Risk Factors after Discharge , 2016, PloS one.
[12] J. Ho,et al. Pharmacist review and its impact on Singapore nursing homes. , 2015, Singapore medical journal.
[13] S. Aburuz,et al. The case for evidence-based pharmaceutical care. , 2015, Research in social & administrative pharmacy : RSAP.
[14] R. Tamblyn,et al. Educating medical trainees on medication reconciliation: a systematic review , 2015, BMC medical education.
[15] A. Hussain,et al. The changing face of pharmacy practice and the need for a new model of pharmacy education. , 2013, Journal of young pharmacists : JYP.
[16] A. Sabzghabaee,et al. Pharmaceutical care for asthma patients: A Developing Country's Experience , 2012, Journal of research in pharmacy practice.
[17] H. Wollersheim,et al. Medication reconciliation at hospital admission and discharge: insufficient knowledge, unclear task reallocation and lack of collaboration as major barriers to medication safety , 2012, BMC Health Services Research.
[18] M. Schulz,et al. Development of a classification system for drug‐related problems in the hospital setting (APS‐Doc) and assessment of the inter‐rater reliability , 2012, Journal of clinical pharmacy and therapeutics.
[19] W. Kuhn,et al. Pharmaceutical care for patients with breast and ovarian cancer , 2012, Supportive Care in Cancer.
[20] P. R. Obreli-Neto,et al. Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients , 2011, International Journal of Clinical Pharmacy.
[21] C. Bradley. The future role of pharmacists in primary care. , 2009, The British journal of general practice : the journal of the Royal College of General Practitioners.
[22] S. Aburuz,et al. Validation of a comprehensive classification tool for treatment-related problems , 2006, Pharmacy World and Science.
[23] A. Siu,et al. Medication reconciliation for reducing drug-discrepancy adverse events. , 2006, The American journal of geriatric pharmacotherapy.
[24] Carole W Cranor,et al. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. , 2006, Journal of the American Pharmacists Association : JAPhA.
[25] R. Clifford,et al. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. , 2005, Diabetes care.
[26] E. Roughead,et al. Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes , 2005 .
[27] M. J. Martín-Calero,et al. Pharmaceutical care: past, present and future. , 2004, Current pharmaceutical design.
[28] C. D. Hepler. Clinical Pharmacy, Pharmaceutical Care, and the Quality of Drug Therapy , 2004, Pharmacotherapy.
[29] D. Christensen,et al. The asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. , 2003, Journal of the American Pharmaceutical Association.
[30] C. Raehl,et al. Clinical Pharmacy Services, Hospital Pharmacy Staffing, and Medication Errors in United States Hospitals , 2002, Pharmacotherapy.
[31] C. Hepler,et al. Opportunities and responsibilities in pharmaceutical care. , 1990, American journal of hospital pharmacy.
[32] L. Hasoun,et al. Potentially inappropriate medications use and its associated factors among geriatric patients: a cross-sectional study based on 2019 Beers Criteria , 2021, Pharmacia.
[33] L. Strand,et al. Pharmaceutical care practice : the patient-centered approach to medication management services , 2012 .
[34] Multinational Association of Supportive Care in Cancer , 2007 .